Risk stratification and avoiding overtreatment in localized prostate cancer

Purpose of reviewSignificant morbidity is associated with overtreatment of clinically localized prostate cancer (PCa). Risk stratification tools such as novel biomarkers, MRI and risk calculators are useful in predicting which patients would benefit from active surveillance. This review examines cur